| P50 | author | Ying-Ju Lai | Q87980068 |
| | Gwo-Jyh Chang | Q90264027 |
| | Hsao-Hsun Hsu | Q58437828 |
| P2093 | author name string | Wei-Jan Chen | |
| | Chung-Chi Huang | |
| | Jong-Hwei S Pang | |
| | Shu-Hui Lin | |
| P2860 | cites work | Diabetes-related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration. | Q43740242 |
| | Protective effect of propylthiouracil independent of its hypothyroid effect on atherogenesis in cholesterol-fed rabbits: PTEN induction and inhibition of vascular smooth muscle cell proliferation and migration | Q45027911 |
| | Activation of phosphatidylinositol 3-kinase, Akt, and mammalian target of rapamycin is necessary for hypoxia-induced pulmonary artery adventitial fibroblast proliferation | Q45121964 |
| | Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension | Q45869636 |
| | Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension | Q46604316 |
| | Transforming growth factor-beta1 upregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PTEN/AKT pathways. | Q51704646 |
| | Cilostazol promotes vascular smooth muscles cell differentiation through the cAMP response element-binding protein-dependent pathway. | Q53240012 |
| | Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha. | Q53492244 |
| | 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension | Q57823873 |
| | cAMP response element-binding protein content is a molecular determinant of smooth muscle cell proliferation and migration | Q74523107 |
| | Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension | Q77822568 |
| | Suppressive effect of prostaglandin E1 on pulmonary hypertension induced by monocrotaline in rats | Q77938909 |
| | PCAF modulates PTEN activity | Q24296629 |
| | Notch3 signaling promotes the development of pulmonary arterial hypertension | Q24310736 |
| | Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism | Q24315753 |
| | Molecular pathogenesis of pulmonary arterial hypertension | Q24634317 |
| | Beta-adrenergic receptor activation in immortalized human urothelial cells stimulates inflammatory responses by PKA-independent mechanisms | Q24810781 |
| | Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs | Q28218337 |
| | Suppression of Akt1 phosphorylation by adenoviral transfer of the PTEN gene inhibits hypoxia-induced proliferation of rat pulmonary arterial smooth muscle cells | Q28581008 |
| | The functions and regulation of the PTEN tumour suppressor | Q29615536 |
| | PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model | Q32069431 |
| | Inhaled iloprost for severe pulmonary hypertension | Q33147955 |
| | Prostacyclin and prostaglandin E1: molecular mechanisms and therapeutic utility | Q33379657 |
| | CREB downregulation in vascular disease: a common response to cardiovascular risk | Q33739408 |
| | A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model | Q33843949 |
| | Reversal of experimental pulmonary hypertension by PDGF inhibition | Q34048479 |
| | Protocol for PTEN expression by immunohistochemistry in formalin-fixed paraffin-embedded human breast carcinoma | Q34066409 |
| | An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension | Q34589929 |
| | A continuum model for tumour suppression | Q34631552 |
| | Role of Akt signaling in vascular homeostasis and angiogenesis | Q34712853 |
| | CREB is a novel nuclear target of PTEN phosphatase | Q35019216 |
| | Subtle variations in Pten dose determine cancer susceptibility | Q35055350 |
| | Prostanoid therapy for pulmonary arterial hypertension. | Q35803359 |
| | PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis | Q35898353 |
| | The nuclear affairs of PTEN. | Q37063858 |
| | Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension | Q37576723 |
| | Mechanisms of disease: pulmonary arterial hypertension. | Q37892336 |
| | CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation | Q38340711 |
| | PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) complex for the treatment of pulmonary arterial hypertension (PAH). | Q39533415 |
| | Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model | Q39879690 |
| | PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. | Q40178894 |
| | Prostanoid receptors and their biological actions | Q40815197 |
| | Dysregulation of PTEN in cardiopulmonary vascular remodeling induced by pulmonary hypertension. | Q41170725 |
| | Platelet-derived growth factor BB induces nuclear export and proteasomal degradation of CREB via phosphatidylinositol 3-kinase/Akt signaling in pulmonary artery smooth muscle cells | Q41491090 |
| | Mechanisms and consequences of activation of protein kinase B/Akt | Q41751003 |
| | Selective inactivation of PTEN in smooth muscle cells synergizes with hypoxia to induce severe pulmonary hypertension | Q41827194 |
| | Influence of PEI as a core modifying agent on PLGA microspheres of PGE₁, a pulmonary selective vasodilator. | Q42775300 |
| | Reduction of reactive oxygen species prevents hypoxia-induced CREB depletion in pulmonary artery smooth muscle cells. | Q42864755 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P2507 | corrigendum / erratum | Author Correction: Prostaglandin E1 Attenuates Pulmonary Artery Remodeling by Activating Phosphorylation of CREB and the PTEN Signaling Pathway | Q90453430 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phosphorylation | Q242736 |
| | alprostadil | Q579348 |
| P304 | page(s) | 9974 | |
| P577 | publication date | 2017-08-30 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Prostaglandin E1 Attenuates Pulmonary Artery Remodeling by Activating Phosphorylation of CREB and the PTEN Signaling Pathway | |
| P478 | volume | 7 | |